Figures computed from official regulatory filings — .
Ownershipinsiders 0% · institutions 0%
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for ORTHOMETRIX INC only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Orthometrix, Inc. develops technologies, procedures, and devices to help increase musculoskeletal mobility, as well as non-invasive technologies to treat the pain associated with osteoarthritis, plantar fasciitis, and other musculoskeletal conditions that reduce mobility. The company markets, sells, and services peripheral quantitative computed tomography bone and muscle measurement systems for research and clinical applications; patented motorized exercise systems for rehabilitation, physical therapy, and sports medicine based on patented vibration technology; human performance measurement systems for monitoring improvement in power and mobility; and extracorporeal shock wave therapy systems for non-invasive treatment of pain associated with plantar fasciitis. It also markets, sells, and services patented motorized exercise systems to professional teams, fitness centers, gyms, sports clubs, and wellness-conscious general public. The company offers bone and muscle diagnostic, bone and muscle research, rehabilitation/physical therapy, sports and fitness, and home products. It serves healthcare, veterinary, and sports and fitness markets in the United States and internationally. The company was formerly known as Norland Medical Systems, Inc. and changed its name to Orthometrix, Inc. in April 2002. Orthometrix, Inc. was founded in 1993 and is headquartered in Naples, Florida.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
20 buys— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| BONMATI REYNALD Gtrack record | ExerciseD (derivative) | $2K | SEC |
| BONMATI REYNALD Gtrack record | ExerciseD (derivative) | $1.5K | SEC |
| BONMATI REYNALD Gtrack record | ExerciseD (derivative) | $2.3K | SEC |
| BONMATI REYNALD Gtrack record | ExerciseD (derivative) | $5K | SEC |
| BONMATI REYNALD Gtrack record | ExerciseD (derivative) | $1.8K | SEC |
| BONMATI REYNALD Gtrack record | ExerciseD (derivative) | $1K | SEC |
| BONMATI REYNALD Gtrack record | ExerciseD (derivative) | $12.5K | Unusual size | SEC |
| BONMATI REYNALD Gtrack record | ExerciseD (derivative) | $1.3K | SEC |
| BONMATI REYNALD Gtrack record | ExerciseD (derivative) | $1.3K | SEC |
| BONMATI REYNALD Gtrack record | ExerciseD (derivative) | $2.3K | SEC |
| BONMATI REYNALD Gtrack record | ExerciseD (derivative) | $2.3K | SEC |
| BONMATI REYNALD Gtrack record | ExerciseD (derivative) | $2.3K | SEC |
| BONMATI REYNALD Gtrack record | ExerciseD (derivative) | $500 | SEC |
| BONMATI REYNALD Gtrack record | ExerciseD (derivative) | $2.3K | SEC |
| BONMATI REYNALD Gtrack record | ExerciseD (derivative) | $12.5K | Unusual size | SEC |
| BONMATI REYNALD Gtrack record | Buy | $1.1K | conv 16 | SEC |
| BONMATI REYNALD Gtrack record | Buy | $1.3K | conv 14 | SEC |
| BONMATI REYNALD Gtrack record | Buy | $1.2K | conv 14 | SEC |
| BONMATI REYNALD Gtrack record | ExerciseD (derivative) | $900 | SEC |
| BONMATI REYNALD Gtrack record | Buy | $2.5K | conv 14 | SEC |
| BONMATI REYNALD Gtrack record | Buy | $1.2K | conv 28 | SEC |
| BONMATI REYNALD Gtrack record | Buy | $750 | conv 29First in 12mo | SEC |
| BONMATI REYNALD Gtrack record | Buy | $1.3K | conv 14 | SEC |
| BONMATI REYNALD Gtrack record | Buy | $1.3K | conv 14 | SEC |
| BONMATI REYNALD Gtrack record | Buy | $1K | conv 14 | SEC |